Dariohealth Corp. insider trading

Every open-market purchase and sale by Dariohealth Corp.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

Insider purchases, 5 years $100,000 1 trade by 1 insider 3 months later: median −54.4% (−58.1% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.

Dariohealth Corp. insider open-market trades
Date	Insider	Trade	Shares	Price	Value	1M after	3M after	6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following Dariohealth Corp.’s insiders pay?

From August 15, 2016 to July 28, 2026, 6 insiders reported 9 open-market purchases and 0 sales not made under a pre-set plan in Dariohealth Corp. Twelve months after each purchase was reported, the shares were +121.5% against the S&P 500 on average (median +203.7%), over 3 purchases with a full year of prices; 67% beat the index. That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on March 24, 2020 into $12,962 by November 2, 2026, +4.0% a year. It held shares 36% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $24,391 (+14.5% a year), and held throughout $34,017 (+20.4%).

Copying Dariohealth Corp.'s insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by Dariohealth Corp.'s insiders from March 24, 2020, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 36% of the time.

Dariohealth Corp.: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	12 months after their sales	Latest report
Nelson Steven Charles	President and CCO	3	−47.1% (1)	0%	—	August 27, 2025
Stern Adam K	Director	2	+205.8% (2)	100%	—	June 9, 2020
Ben-David Zvi	Chief Financial Officer	1	—	—	—	March 2, 2018
Matheis Dennis	Director	1	—	—	—	July 28, 2026
Raphael Erez	Chief Executive Officer	1	—	—	—	August 15, 2016
Shaked Yoav	Director	1	—	—	—	September 26, 2018

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Dariohealth Corp. · Funds · Politicians